AP2014008162A0 - Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure - Google Patents

Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure

Info

Publication number
AP2014008162A0
AP2014008162A0 AP2014008162A AP2014008162A AP2014008162A0 AP 2014008162 A0 AP2014008162 A0 AP 2014008162A0 AP 2014008162 A AP2014008162 A AP 2014008162A AP 2014008162 A AP2014008162 A AP 2014008162A AP 2014008162 A0 AP2014008162 A0 AP 2014008162A0
Authority
AP
ARIPO
Prior art keywords
lack
oxygen
treatment
pharmaceutical composition
air pressure
Prior art date
Application number
AP2014008162A
Other languages
English (en)
Inventor
Rudolf Lucas
Bernhard Fischer
Hendrik Fischer
Original Assignee
Apeptico Forschung & Entwicklung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48672620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2014008162(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apeptico Forschung & Entwicklung Gmbh filed Critical Apeptico Forschung & Entwicklung Gmbh
Publication of AP2014008162A0 publication Critical patent/AP2014008162A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AP2014008162A 2012-06-28 2013-06-19 Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure AP2014008162A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12173983.3A EP2679239A1 (de) 2012-06-28 2012-06-28 Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit
PCT/EP2013/062777 WO2014001177A1 (de) 2012-06-28 2013-06-19 Pharmazeutische zusammensetzung zur behandlung der durch sauerstoffarmut und verringerten luftdruck vermittelten pulmonalen form der höhenkrankheit

Publications (1)

Publication Number Publication Date
AP2014008162A0 true AP2014008162A0 (en) 2014-12-31

Family

ID=48672620

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2014008162A AP2014008162A0 (en) 2012-06-28 2013-06-19 Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure

Country Status (14)

Country Link
US (2) US9802985B2 (OSRAM)
EP (2) EP2679239A1 (OSRAM)
JP (1) JP6113277B2 (OSRAM)
KR (1) KR102010793B1 (OSRAM)
CN (1) CN104427993B (OSRAM)
AP (1) AP2014008162A0 (OSRAM)
AU (1) AU2013283563B2 (OSRAM)
CA (1) CA2875749C (OSRAM)
EA (1) EA030384B1 (OSRAM)
ES (1) ES2602197T3 (OSRAM)
IN (1) IN2015DN00585A (OSRAM)
MX (1) MX354302B (OSRAM)
PE (1) PE20150198A1 (OSRAM)
WO (1) WO2014001177A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015132294A1 (en) * 2014-03-04 2015-09-11 Apeptico Forschung Und Entwicklung Gmbh Attenuation of intrapulmonary inflammation
JP6397984B2 (ja) * 2014-03-18 2018-09-26 アペプティコ・フォルシュング・ウント・エントヴィックルング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＡｐｅｐｔｉｃｏ Ｆｏｒｓｃｈｕｎｇ Ｕｎｄ Ｅｎｔｗｉｃｋｌｕｎｇ Ｇｍｂｈ 乾燥粉末ペプチド医薬
KR20180041749A (ko) 2015-08-25 2018-04-24 바-일란 유니버시티 비대칭형 전기 화학 전지 장치 및 그 작동 방법
EP3624885A4 (en) 2017-05-19 2021-03-10 Trudell Medical International EXPIRATORY OVERPRESSURE DEVICE
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud
WO2021087037A1 (en) * 2019-10-29 2021-05-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lung-specific targeting-peptide (ltp), compositions, and uses thereof
EP4051307B1 (en) 2020-05-08 2023-02-01 APEPTICO Forschung und Entwicklung GmbH Peptide for prevention or treatment of covid-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
CA2155103A1 (en) 1993-02-03 1994-08-18 Rudolph Lucas Tnf-alpha muteins and a process for preparing them
NZ509604A (en) 1998-08-14 2003-05-30 Innogenetics N TNF-derived peptides for use in treating oedema
EP1781323B1 (en) 2004-08-06 2010-02-17 Nycomed GmbH Composition comprising a pulmonary surfactant and a tnf-derived peptide
EP2009023A1 (en) 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
AT506150B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
CA2791847C (en) * 2009-03-04 2017-05-02 Mannkind Corporation An improved dry powder drug delivery system
AT507953B1 (de) * 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase

Also Published As

Publication number Publication date
EP2866824A1 (de) 2015-05-06
ES2602197T3 (es) 2017-02-20
AU2013283563A1 (en) 2015-01-15
EP2679239A1 (de) 2014-01-01
CA2875749A1 (en) 2014-01-03
KR102010793B1 (ko) 2019-08-14
CA2875749C (en) 2019-02-26
KR20150037815A (ko) 2015-04-08
PE20150198A1 (es) 2015-02-19
JP2015526399A (ja) 2015-09-10
CN104427993A (zh) 2015-03-18
CN104427993B (zh) 2017-03-08
AU2013283563B2 (en) 2017-06-08
EA201500061A1 (ru) 2015-06-30
WO2014001177A1 (de) 2014-01-03
EA030384B1 (ru) 2018-07-31
MX2014015048A (es) 2015-06-05
US20150225460A1 (en) 2015-08-13
EP2866824B1 (de) 2016-08-10
JP6113277B2 (ja) 2017-04-12
IN2015DN00585A (OSRAM) 2015-06-26
MX354302B (es) 2018-02-23
US9802985B2 (en) 2017-10-31
US20190211061A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
AP2014008162A0 (en) Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure
ZA201500593B (en) Activators of ampk and therapeutic uses thereof
IL238204A0 (en) Methods and systems for transporting oxygen-enriched gas
IL233674B (en) Preparations and methods for using phorbol esters for stroke treatment
DK2916852T3 (en) A porous silica material for use as a pharmaceutical or dietary active ingredient
EP2675478A4 (en) COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF GRIP
IL235831A0 (en) A new dosage form and formulation of aveditrol
IL236655A0 (en) Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and improved preparations containing calcium for the treatment of hyperkalemia
AU339359S (en) Respiratory mask and/or components thereof
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
SI2874600T1 (sl) Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu
ZA201306905B (en) Novel octahydrothienoquinonline derivative,pharmaceutical composition comprising derivative, and use of these
GB2504390B (en) Nutraceutical and pharmaceutical composition
IL227666A0 (en) Aclidinium for use in improving the quality of sleep in respiratory patients
PL2812058T3 (pl) Urządzenie do regulacji przepływu tlenu i/lub powietrza do końcówek donosowych
IL238209A (en) A process for generating variconazole and its analogs
IL233961B (en) The composition of a phytogenic supplement and methods of its use
ZA201308905B (en) Nasal pharmaceutical formulation comprising fluticasone
EP2866792A4 (en) MICROPARTICLE FORMULATIONS FOR DELIVERY TO LOWER AND CENTRAL RESPIRATORY PATHS AND METHOD OF PREPARING THEM
HUE036419T2 (hu) Légzõszervi depresszió kezelése
GB2508897B (en) Oxygen flow controller for medical use
EP2861586A4 (en) FORMS OF VILAZODONE AND METHODS OF PREPARATION THEREOF
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure
EG27014A (en) Apparatus for clearing the air from CO2 convertingit to oxygen and sterilize the air
WO2013109213A3 (en) Pharmaceutical formulations comprising tiotropium